1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • February 2015
  • -
  • BCC Research
  • -
  • 123 pages

REPORT HIGHLIGHTS

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

This report provides:

An overview of the global markets and technologies for the therapeutics for "silent" cancers.
Analyses of global market trends, with data from 2013, 2014, and projections of CAGRs through 2019.
Descriptions of cancers, with incidence and prevalence data for all major national markets.
Assessments of currently available therapies.
Evaluation of new agents now in clinical development, with likely launch timetables and estimates of potential clinical value.
Profiles of major players in the "silent" cancer therapeutics industry.

SCOPE OF REPORT

The report discusses eight cancers described as “silent and deadly” because they are often undiagnosed until the diseases is advanced and difficult to treat. These cancers are brain, cervix, esophagus, mouth and larynx, ovary, pancreas, kidney, and lastly, liver. For each cancer, the cause, clinical course, diagnosis and treatment are described. Current drug therapy is outlined and new research activities are listed. The market is summarized and quantified for each cancer, with estimates of recent (2013) and current (2014) values for each cancer, and five-year projection to 2019. Geographically, the global market is given, with country analyses for the U.S., Japan, and five major Western European markets: Germany, France, Italy, Spain and the United Kingdom.

Table Of Contents

Therapeutics for ”Silent” Cancers

Chapter- 1: INTRODUCTION - Complimentary 3

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 4

Table Summary : GLOBAL MARKET FOR "SILENT" CANCERS, THROUGH 2019
Figure Summary : GLOBAL MARKET SHARE FOR

Chapter- 3: OVERVIEW 7

CANCER: A GLOBAL PERSPECTIVE
GROWING PROBLEM
MARKET DYNAMICS
SOME LEADING ANTICANCER DRUGS
ASYMPTOMATIC CANCER

Chapter- 4: BRAIN CANCER 10

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW DEVELOPMENTS IN RESEARCH
MARKET

Chapter- 5: CANCER OF THE MOUTH AND LARYNX 7

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
LARYNGEAL CANCER
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 6: CANCER OF THE ESOPHAGUS 6

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 7: LIVER CANCER 7

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
OTHER PRIMARY LIVER CANCERS
METASTASES
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 8: RENAL CANCER 8

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 9: CANCER OF THE PANCREAS 9

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 10: CANCER OF THE CERVIX 9

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
NEW RESEARCH DEVELOPMENTS
MARKET

Chapter- 11: OVARIAN CANCER 17

CAUSE, FREQUENCY AND COURSE
DIAGNOSIS
TREATMENT
OVARIAN CANCER SCREENING
NEW DEVELOPMENTS IN TREATMENT
MARKET

Chapter- 12: TUMOR MARKERS 10

SCREENING AND EARLY DETECTION
DIAGNOSING CANCER
MONITORING
TUMOR MARKERS FOUND ON THE CANCER ITSELF
NEW DIRECTIONS IN TUMOR MARKER RESEARCH

Chapter- 13: COMPANY PROFILES 18

ABBOTT LABORATORIES
ADVAXIS
AMGEN
APP PHARMACEUTICALS
ASTRAZENECA
BAYER
BIONUMERIK PHARMACEUTICALS
BOEHRINGER INGELHEIM GMBH
BRISTOL-MYERS SQUIBB
CELL THERAPEUTICS INC.
CHUGAI PHARMACEUTICAL
CLOVIS ONCOLOGY
DENDREON CORP.
DIGENE CORP.
EISAI INC.
ELI LILLY AND COMPANY
ENDOCYTE
FUJIREBIO DIAGNOSTICS
GE HEALTHCARE
GENENTECH
GLAXOSMITHKLINE
ISA PHARMACEUTICALS
JOHNSON and JOHNSON
LPATH
MERCK
MYRIAD GENETICS
NOVOCURE
OASMIA PHARMACEUTICAL
ONCOLYTICS
OXIGENE
PFIZER
PROVISTA DIAGNOSTICS
QIAGEN
QUEST DIAGNOSTICS
RADIENT PHARMACEUTICALS
ROCHE DIAGNOSTICS
SANOFI
TELIK INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
ZILICO

Chapter- 14: APPENDIX 1: GLOSSARY 8

List of Tables

Summary Table : GLOBAL MARKET FOR "SILENT" CANCERS, THROUGH 2019
Table 1 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR BRAIN CANCER
Table 2 : GLOBAL AND U.S. BRAIN CANCER MARKET, THROUGH 2019
Table 3 : BRAIN CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 4 : BRAIN CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 5 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR HEAD AND NECK CANCER
Table 6 : GLOBAL AND U.S. MOUTH AND LARYNX CANCER MARKET, THROUGH 2019
Table 7 : MOUTH AND LARYNX CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 8 : CANCER OF MOUTH AND LARYNX FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 9 : COMPOUNDS IN CLINICAL DEVELOPMENT FOR ESOPHAGEAL CANCER
Table 10 : GLOBAL AND U.S. ESOPHAGEAL CANCER MARKET, THROUGH 2019
Table 11 : ESOPHAGEAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 12 : ESOPHAGEAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 13 : LIVER CANCER: NEW DEVELOPMENTS IN RESEARCH
Table 14 : GLOBAL AND U.S. LIVER CANCER MARKET, THROUGH 2019
Table 15 : LIVER CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 16 : LIVER CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 17 : RENAL CANCER: NEW RESEARCH DEVELOPMENTS
Table 18 : GLOBAL AND U.S. RENAL CANCER MARKET, THROUGH 2019
Table 19 : RENAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 20 : RENAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 21 : PANCREATIC CANCER: NEW RESEARCH DEVELOPMENTS
Table 22 : GLOBAL AND U.S. PANCREATIC CANCER MARKET, THROUGH 2019
Table 23 : PANCREATIC CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 24 : PANCREATIC CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 25 : NEW RESEARCH DEVELOPMENTS IN CERVICAL CANCER
Table 26 : GLOBAL AND U.S. CERVICAL CANCER MARKET, THROUGH 2019
Table 27 : CERVICAL CANCER MARKET FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 28 : CERVICAL CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019
Table 29 : NEW DEVELOPMENTS IN OVARIAN CANCER RESEARCH
Table 30 : GLOBAL AND U.S. OVARIAN CANCER MARKET, THROUGH 2019
Table 31 : OVARIAN CANCER MARKET, FOR MAJOR EUROPEAN COUNTRIES, THROUGH 2019
Table 32 : OVARIAN CANCER MARKET FOR JAPAN AND REST OF WORLD, THROUGH 2019

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US and South Korea

  • November 2016
    2 pages
  • Cancer  

  • United States  

    South Korea  

View report >

Therapy Market in the UK

  • November 2016
    11 pages
  • Therapy  

  • United Kingdom  

View report >

Cancer and Breast Cancer Statistics in the US

  • November 2016
    9 pages
  • Cancer  

    Breast Cancer  

    Cytokine  

  • United States  

View report >

Related Market Segments :

Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.